GoldBamboo.com - Knowledge is strong medicine
  

Preventing Child Abuse in Infants - Article


  Not Signed In - Sign In / Register







[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Youth Risk Behavior Surveillance System

YRBSS




Clinical Trial: Preventing Child Abuse in Infants

This study is no longer recruiting patients.

Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)

Purpose

The purpose of this study is to compare 2 approaches (interventions) to prevent child-abuse (maltreatment) in infants: Psychoeducational Home Visitation (PHV) vs Infant-Parent Psychotherapy (IPP). Non-maltreated infants and their mothers are studied as a comparison group.

Twelve-month-old infants and their mothers are assigned randomly (like tossing a coin) to receive 1 of 3 types of intervention for 12 months: 1) Services normally available in the community when a family is reported for child maltreatment (Child Protective Services, CPS); 2) CPS involvement plus weekly PHV; 3) CPS involvement plus weekly IPP. Intervention will be provided until the infant's second birthday. All mother-infant pairs (including comparison non-maltreated infants and their mothers) will be assessed when the infant is 12, 18, 24, 36, and 48 months old. Assessments will look at the effectiveness of the intervention in preventing child maltreatment, improving parenting, and reducing future abuse. The study will last for 3 years.

Eligibility includes a mother and her 12-month-old child that has been abused by her (the mother) or the father. (Non-maltreated infants and their mothers also will be enrolled.)

Condition Treatment or Intervention Phase
Child Abuse
 Behavior: Infant-Parent Psychotherapy
 Behavior: Child Protective Services
 Behavior: Psychoeducational Home Visitation
 Behavior: Parent Education
Phase III

MedlinePlus consumer health information 

Study Type: Interventional
Study Design: Prevention, Randomized

Official Title: Preventive Intervention for Maltreated Infants

Further Study Details: 

Study start: July 1998;  Study completion: June 2003

To evaluate the relative effectiveness of 2 theoretically-informed approaches to preventing the adverse sequelae of maltreatment in infants: Psychoeducational Home Visitation (PHV) and Infant-Parent Psychotherapy (IPP). Non-maltreated infants and their mothers serve as a comparison.

Maltreated infants and their mothers are randomly assigned to 1 of 3 types of intervention for 12 months: 1) Services routinely available in the community when a family is reported for child maltreatment (Child Protective Services, CPS); 2) CPS involvement plus weekly PHV; 3) CPS involvement plus weekly IPP. Intervention is provided until the infant's second birthday. All mother-infant dyads (including comparison non-maltreated infants and their mothers) participate in baseline assessments at the infant's age of 12 months. Subsequent assessments occur at 18, 24, 36, and 48 months of age. Assessments measure three major areas: 1) family-ecological variables; 2) maternal functioning and parenting; and 3) child functioning and stage-salient issues. CPS records are monitored annually across all groups to determine whether any reports of maltreatment have been filed.

Eligibility

Ages Eligible for Study:  12 Months   -   12 Months,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

    Participants must have: Infants that have been maltreated by their biological caregiver during their first year of life and who continue to reside with their maternal caregiver. (Non-maltreated infants and their mothers will also be enrolled.)


    Location Information

    Study chairs or principal investigators

    Dante Cicchetti, PhD,  Principal Investigator

    More Information

    Study ID Numbers:  MH54643
    Record last reviewed:  June 2002
    Last Updated:  October 13, 2004
    Record first received:  November 2, 1999
    ClinicalTrials.gov Identifier:  NCT00000382
    Health Authority: United States: Federal Government
    ClinicalTrials.gov processed this record on 2005-04-08


    Source: ClinicalTrials.gov
    Cache Date: April 9, 2005

    Resources



    Take control over your directory listings...INSTANTLY

    Every day, thousands of users find businesses like yours in the GoldBamboo directory.

    Limited Time Offer!!!

    For only $50 a year, a savings of 50% off our standard rate:

    • Edit your listing (whenever you want!)
    • Link to your website
    • Choose which categories you are listed in
    • Describe your services

    The process will take only a few minutes and consists of 3 easy steps:

    1. Register     >     2. Edit Listings     >     3. Publish

    Your Company
    your street
    yourtown, YS 12345
    888-888-8888



    No Thanks

    Popular Treatments

    Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
    Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
    Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
    Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
    Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
    Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
    Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
    Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
    Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
    Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
    High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
    Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
    Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
    Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
    Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
    Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
    Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
    Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
    Testicular Cancer Treatment
    GoldBambooTM

    Your Integrative Health and Wellness Resource for Youth Risk Behavior Surveillance System.

    December 1, 2008



    Page Updated: November 22, 2004
    ============== Advertisement ==============
    Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

    Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

    Copyright © 2004-2008 - Gold Bamboo LLC - All rights reserved.

    HONcode accreditation seal.

    We comply with the HONcode standard for health trust worthy information:
    verify here.